Trial intelligence / Profile preview

Intrathecal Magnesium Sulfate Dosing for Post-Spinal Shivering in Cesarean Section

NCT05427149Completed

Sponsor
Van Yuzuncu Yil University
Start
May 2022
Primary completion
Jun 2022
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of magnesium sulfate in postoperative shivering (4 arms), sponsored by Van Yuzuncu Yil University. Primary endpoint: Level of shivering at 3 months. Started May 2022; status: completed.

02

Drugs

magnesium sulfate
03

Conditions

postoperative shivering

Beyond the preview

Go deeper on NCT05427149.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05427149.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call